Goldman Sachs notes that Vera Therapeutics (VERA) shares are down 18% and underperforming the biotech group today following earnings results from Otsuka that included a comment on potential at ...

After years of bashing cryptocurrencies, US investment bank Goldman Sachs has admitted it was wrong about the asset class. Not in words, but with actions. The investment giant, which manages ...

Diamond has comanaged this strategy since the end of 2002, the same year he joined Goldman Sachs Asset Management after nine years with Prudential's muni group. The firm officially appointed Yeh ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Wells Fargo notes that Vera Therapeutics (VERA) shares are down about 20% today, which the firm attributes to competitor Otsuka saying they will make a prefilled syringe version of the company’s ...

Bitcoin and ethereum have diverged in recent months, with the bitcoin price soaring as ethereum struggles—helped by U.S. president Donald Trump’s predicted plans for bitcoin. The bitcoin price ...

"How can we help?" is the question we ask ourselves every day. I have been proudly leading the Contact 6 segment since 2016. Our goal is simple: to make a positive difference in our community.